 |
 |
 |
 |
 |
 |
 |
 |
-
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy- Complications of HIV/HAART
- Research & Development
- Clinical Trials
- Quality of Life & Patient Care
Antiretroviral Therapy
Complications of HIV/HAART: General Research
- Severe Events Unrelated to AIDS or Antiretrovirals Were Most Common in Early HAART Patients (December 16, 2005)
In The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy - Five Ways to Tackle Toxicity (or the Ant, the Spider, and the Bee): 6th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV (January 2005)
To read PDF, click here
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Deaths Down for People With AIDS; Causes Shift From AIDS- to Age-Related Diseases (February 9, 2004)
In The 11th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Quality of Life Impact of Non-AIDS-Related Serious Adverse Events Versus AIDS-Related Events (February 9, 2004)
In The 11th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Risk of Death Following Triple-Class Virological Failure (September 14, 2003)
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO - U.S.-Born Latinos More Prone to HIV Complications Than Foreign-Born (August 5, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - UC-Davis Study Will Investigate When to Treat Opportunistic Infections (June 13, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Opportunistic Infection Prophylaxis Can Be Safely Dropped After CD4 Recovery (November 15, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Study Examines Mortality Factors in HIV Patients on Protease Inhibitors (October 10, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Successful Antiretroviral Treatment Has Little Effect on Overall Immune Function (August 12, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Scientists Explore Role of STDs, Malaria, and TB in Africa (August 9, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Symptoms of Depressed HIV Patients Not Just Psychological (August 7, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Continued Benefit From Highly Active Antiretroviral Therapy: Trends in AIDS-Related Opportunistic Illnesses in a Public Health Care System, 1990-2001 (July 11, 2002)
In The XIV International AIDS Conference, from The Body PRO - Earlier Initiation of HAART Better Preserves Functional Immune Competence Even in Persons Who Achieve "Normal" CD4+ T-Cell Counts (July 11, 2002)
In The XIV International AIDS Conference, from The Body PRO - Impact of Highly Active Antiretroviral Therapy on Individual AIDS-Defining Illness Incidence and Survival in Australia (June 11, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Cause of Serious Illness Among HAART Users Not Clear (March 19, 2002)
From Canadian AIDS Treatment Information Exchange - Discontinuing Primary and Secondary PCP Prophylaxis in Patients Who Have Increased CD4 Counts in Response to Antiretroviral Therapy: Preliminary Results -- ACTG 888 (January 31, 2000)
In The 7th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Prevention of Opportunistic Infections Other Than Mycobacterium Avium Complex in a Randomized, Placebo-Controlled Trial of Azithromycin (AZ) Prophylaxis in Subjects With Increases in CD4 Cells on Antiretroviral Therapy -- Preliminary Results (January 31, 2000)
In The 7th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
  |
  |